High value care Program Leadership
High Value Care Corporate Steering Committee
Chair
Dr. Michael McKenna, EVP / CMO MHC
Members
Dr. Dennis Spender, CMO McLaren Laboratory
Dr. Brad Ropp, CMO McLaren Medical Group
Dr. Sara Liter-Kuester, Cerner Project Physician Lead
Dr. Robert Flora, Chief Academic Officer MHC
Dr. Binesh Patel, CMO McLaren Flint
Dr. Kevin Carter, Chief of Staff McLaren Lapeer
Dr. Michael Ziccardi, Medical Director McLaren Physician Practice
Dr. Erlene Seymour, Karmanos Cancer Center
Dr. Asif Ishaque, Chair, PMC ACO
Dr. Tim Hannon, CEO Healthcare Forward
Chandan Gupte, VP Clinical Excellence MHC
Danette Hayman, Director Corporate Quality MHC
Don Henderson, VP McLaren Laboratory
Dr. Carlos Rios-Bedoya, Corporate Director of Scholarly Inquiry
Bernie Adams, SSBB, Director of Performance Improvement Education
Repetitive Testing Task Force
Co-chairs
Dr. Neil Caliman, Pathology Medical Director Greater Lansing
Dr. Anil Kumar, Critical Care Medical Director Greater Lansing
Members
Dr. Andrew McDonagh, CMO Northern
Dr. Binesh Patel, CMO Flint
Dr. Tim Hannon, CEO Healthcare Forward
Dr. Heather Signorelli, Medical Director Healthcare Forward
Chandan Gupte, VP Clinical Excellence and Research
Danette Hayman, Corporate Director of Quality
Don Henderson, VP McLaren Laboratory
Reference Lab Testing Task Force
Co-chairs
Dr. Shane Starr, Pathology Medical Director McLaren Bay Region
Dr. Erlene Seymour, Oncologist Karmanos Cancer Center
Members
Dr. Paul Swerdlow, Hematologist Karmanos Cancer Center
Dr. Tim Hannon, CEO Healthcare Forward
Dr. Heather Signorelli, Medical Director Healthcare Forward
Chandan Gupte, VP Clinical Excellence and Research
Danette Hayman, Corporate Director of Quality
Don Henderson, VP McLaren Laboratory
Antimicrobial Stewardship Task Force
Members
Dr. Jon Sangeorzan, Infectious Disease McLaren Northern
Dr. Dennis Spender, CMO McLaren Labs
Dr. Aaron Goldfarb, Pathology Medical Director McLaren Port Huron
Dr. Binesh Patel, CMO McLaren Flint
Dr. Tim Hannon, CEO Healthcare Forward
Dr. Heather Signorelli, Medical Director Healthcare Forward
Brian Hatcher, Microbiology Director McLaren Labs
Lisa Engles, Epidemiology Coordinator Karmanos Cancer Center
Karolina Kaser, Infection Preventionist McLaren Oakland
Imaging Appropriate Use Criteria Task Force
Co-chairs
Dr. Kevin Carter, Radiology Medical Director McLaren Oakland
Mark Gray, Corporate Director Information Technology
Members
Dr. Sara Liter-Kuester, ONE McLaren Physician Lead
Dr. Brad Ropp, CMO McLaren Medical Group
Dr. Michael Ziccardi, CMO McLaren Physician Partners
Dr. Tressa Gardner, Regional Medical Director American Physician Partners
Dr. Tim Hannon, CEO Healthcare Forward
Chandan Gupte, VP Clinical Excellence and Research
Danette Hayman, Corporate Director of Quality
Janelle Spann, Director Imaging Services
Kimberly Segal, Corporate Manager Revenue Integrity
Melissa Benchley, Regional Director Patient Access, McLaren Northern Michigan
Kim Chaltry, Director of Medical Imaging Services and Radiation Oncology, McLaren Port Huron
Brina Rolison, Quality Improvement Analyst
High Sensitivity Troponin Working Group
Members
Dr. Dennis Spender, CMO McLaren Labs
Dr. Timothy Logan, Cardiologist, Macomb
Dr. Nicolas Mouawad, Bay Heart & Vascular
Dr. Tressa Gardner, Executive Medical Director, American Physician Partners
Dr. Raymond Rudoni, Emergency Medicine Medical Director, McLaren Flint
Dr. Bob Flora, Chief Academic Officer MHC
Dr. Tim Hannon, CEO Healthcare Forward
Betsy Felton, Corporate Director of Cardiovascular Service Line
Chandan Gupte, VP Clinical Excellence MHC
Danette Hayman, Director Corporate Quality MHC
Brina Anderson, Quality Improvement Analyst MHC